研究动态
Articles below are published ahead of final publication in an issue. Please cite articles in the following format: authors, (year), title, journal, DOI.

LUBAC 通过激活经典 NF-κB 来促进肿瘤促进 LTβ 受体信号传导。

LUBAC enables tumor-promoting LTβ receptor signaling by activating canonical NF-κB.

发表日期:2024 Aug 30
作者: Yu-Guang Chen, Eva Rieser, Amandeep Bhamra, Silvia Surinova, Peter Kreuzaler, Meng-Hsing Ho, Wen-Chiuan Tsai, Nieves Peltzer, Diego de Miguel, Henning Walczak
来源: CELL DEATH AND DIFFERENTIATION

摘要:

淋巴毒素 β 受体 (LTβR) 是 TNF 受体超家族 (TNFR-SF) 的成员,对于淋巴器官的发育和成熟至关重要。此外,LTβR 激活通过诱导促炎分泌组促进癌发生。然而,我们目前缺乏对 LTβR 信号传导的详细了解。在这项研究中,我们发现线性泛素链组装复合物 (LUBAC) 是天然 LTβR 信号复合物 (LTβR-SC) 的一个先前未被识别且功能上至关重要的组成部分。从机制上讲,LUBAC 生成的线性泛素链能够将 NEMO、OPTN 和 A20 招募到 LTβR-SC,在那里它们协调作用,调节经典和非经典 NF-κB 通路之间的平衡。因此,与死亡受体信号传导不同,LUBAC 通过抑制细胞死亡来预防炎症,而在 LTβR 信号传导中,LUBAC 通过启用规范和干扰非规范 NF-κB 激活来实现炎症信号传导。这导致 LUBAC 依赖性 LTβR 驱动的炎症、促肿瘤分泌组。有趣的是,在 LTβR 高表达的肝癌患者中,LUBAC 高表达与预后不良相关,这为 LUBAC 介导的炎症 LTβR 信号传导提供了临床相关性。© 2024。作者。
Lymphotoxin β receptor (LTβR), a member of the TNF receptor superfamily (TNFR-SF), is essential for development and maturation of lymphoid organs. In addition, LTβR activation promotes carcinogenesis by inducing a proinflammatory secretome. Yet, we currently lack a detailed understanding of LTβR signaling. In this study we discovered the linear ubiquitin chain assembly complex (LUBAC) as a previously unrecognized and functionally crucial component of the native LTβR signaling complex (LTβR-SC). Mechanistically, LUBAC-generated linear ubiquitin chains enable recruitment of NEMO, OPTN and A20 to the LTβR-SC, where they act coordinately to regulate the balance between canonical and non-canonical NF-κB pathways. Thus, different from death receptor signaling, where LUBAC prevents inflammation through inhibition of cell death, in LTβR signaling LUBAC is required for inflammatory signaling by enabling canonical and interfering with non-canonical NF-κB activation. This results in a LUBAC-dependent LTβR-driven inflammatory, protumorigenic secretome. Intriguingly, in liver cancer patients with high LTβR expression, high expression of LUBAC correlates with poor prognosis, providing clinical relevance for LUBAC-mediated inflammatory LTβR signaling.© 2024. The Author(s).